Two non-psychoactive cannabis compounds, cannabidiol (CBD) and cannabigerol (CBG), could offer new treatment options for metabolic dysfunction-associated steatotic liver disease (MASLD), according to research published in…
A preclinical study, published in the journal Pharmacological Research, has found that regular administration of very low doses of psilocybin improved metabolic health in mice with…
